Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Expert Review of Vaccines|March 26, 2011
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccinesJan Poolman, Ray BorrowNPJ Vaccines|December 11, 2021
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccinesChakkumkal Anish, Michel Beurret, Jan PoolmanExpert Review of Vaccines|October 14, 2005
Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?Fabrice Godfroid, Philippe Denoël, Jan PoolmanVaccine|July 6, 2010
Glycoconjugate vaccines and immune interference: A reviewRon Dagan, Jan Poolman, Claire-Anne SiegristVaccine|January 30, 2007
ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis mediaLode Schuerman, Roman Prymula, Isabelle Henckaerts, et al.Clinical and Vaccine Immunology : CVI|March 9, 2006
Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric seraIsabelle Henckaerts, David Goldblatt, Lindsey Ashton, et al.Expert Review of Vaccines|November 3, 2011
Glycoconjugate vaccines and immune interactions, and implications for vaccination schedulesRay Borrow, Ron Dagan, Fred Zepp, et al.Vaccine|October 7, 2008
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 yearsLars Ostergaard, Edouard Lebacq, Jan Poolman, et al.Vaccine|February 15, 2011
Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharidesPhilippe Denoël, Fabrice Godfroid, Philippe Hermand, et al.Pageof 6